Betts G - Search Results

1

Transiently Activated Human Regulatory T Cells Upregulate BCL-XL Expression and Acquire a Functional Advantage in vivo.

Issa F, Milward K, Goto R, Betts G, Wood KJ, Hester J. Issa F, et al. Among authors: betts g. Front Immunol. 2019 Apr 24;10:889. doi: 10.3389/fimmu.2019.00889. eCollection 2019. Front Immunol. 2019. PMID: 31068951 Free PMC article.

2

CD45RA Distinguishes CD4+CD25+CD127-/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression.

Arroyo Hornero R, Betts GJ, Sawitzki B, Vogt K, Harden PN, Wood KJ. Arroyo Hornero R, et al. Transplantation. 2017 Feb;101(2):302-309. doi: 10.1097/TP.0000000000001278. Transplantation. 2017. PMID: 28118317 Free PMC article.

3

Examination of serum miRNA levels in kidney transplant recipients with acute rejection.

Betts G, Shankar S, Sherston S, Friend P, Wood KJ. Betts G, et al. Transplantation. 2014 Feb 27;97(4):e28-30. doi: 10.1097/01.TP.0000441098.68212.de. Transplantation. 2014. PMID: 24531825 No abstract available.

4

Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity.

Simon AK, Jones E, Richards H, Wright K, Betts G, Godkin A, Screaton G, Gallimore A. Simon AK, et al. Among authors: betts g. Eur J Immunol. 2007 Mar;37(3):758-67. doi: 10.1002/eji.200636593. Eur J Immunol. 2007. PMID: 17294404 Free PMC article.

5

Expansion of hepatitis C-specific CD4+CD25+ regulatory T cells after viral clearance: a mechanism to limit collateral damage?

Godkin A, Ng WF, Gallagher K, Betts G, Thomas HC, Lechler RI. Godkin A, et al. Among authors: betts g. J Allergy Clin Immunol. 2008 May;121(5):1277-1284.e3. doi: 10.1016/j.jaci.2008.01.070. Epub 2008 Mar 19. J Allergy Clin Immunol. 2008. PMID: 18355912

6

CD59 blockade enhances antigen-specific CD4+ T cell responses in humans: a new target for cancer immunotherapy?

Sivasankar B, Longhi MP, Gallagher KM, Betts GJ, Morgan BP, Godkin AJ, Gallimore AM. Sivasankar B, et al. J Immunol. 2009 May 1;182(9):5203-7. doi: 10.4049/jimmunol.0804243. J Immunol. 2009. PMID: 19380765 Free PMC article.

7

CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer.

Clarke SL, Betts GJ, Plant A, Wright KL, El-Shanawany TM, Harrop R, Torkington J, Rees BI, Williams GT, Gallimore AM, Godkin AJ. Clarke SL, et al. PLoS One. 2006 Dec 27;1(1):e129. doi: 10.1371/journal.pone.0000129. PLoS One. 2006. PMID: 17205133 Free PMC article.

8

Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors.

Hindley JP, Ferreira C, Jones E, Lauder SN, Ladell K, Wynn KK, Betts GJ, Singh Y, Price DA, Godkin AJ, Dyson J, Gallimore A. Hindley JP, et al. Cancer Res. 2011 Feb 1;71(3):736-46. doi: 10.1158/0008-5472.CAN-10-1797. Epub 2010 Dec 13. Cancer Res. 2011. PMID: 21156649 Free PMC article.

9

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection.

Betts G, Poyntz H, Stylianou E, Reyes-Sandoval A, Cottingham M, Hill A, McShane H. Betts G, et al. PLoS One. 2012;7(12):e50447. doi: 10.1371/journal.pone.0050447. Epub 2012 Dec 21. PLoS One. 2012. PMID: 23284637 Free PMC article.

10

Regulating the immune response to tumours.

Betts GJ, Clarke SL, Richards HE, Godkin AJ, Gallimore AM. Betts GJ, et al. Adv Drug Deliv Rev. 2006 Oct 1;58(8):948-61. doi: 10.1016/j.addr.2006.05.006. Epub 2006 Aug 17. Adv Drug Deliv Rev. 2006. PMID: 17070961 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters